TherapeuticsMD (TXMD) Inventory (2010 - 2022)

TherapeuticsMD has reported Inventory for 13 years, with the latest figure at $6.7 million in Q3 2022.

• For the quarter ending Q3 2022, Inventory fell 8.98% year-over-year to $6.7 million; the trailing twelve-month figure through Sep 2022 stood at $6.7 million (down 8.98% YoY), and the FY2021 full-year result was $7.6 million, down 4.64% from the prior year.
• Inventory for Q3 2022 stood at $6.7 million, up from $6.1 million in the prior quarter.
• The five-year high for Inventory was $14.6 million in Q1 2020, with the low at $1.6 million in Q1 2018.
• Historically, Inventory has averaged $7.3 million across 5 years, with a median of $7.5 million in 2019.
• Annual changes were most pronounced in 2019 — Inventory surged 342.89% — and 2021, when it tumbled 49.71%.
• TherapeuticsMD's Inventory stood at $3.3 million in 2018, then surged by 262.97% to $11.9 million in 2019, then slumped by 32.61% to $8.0 million in 2020, then dropped by 4.64% to $7.6 million in 2021, then dropped by 12.08% to $6.7 million in 2022.
• The last three Inventory figures came in at $6.7 million (Q3 2022), $6.1 million (Q2 2022), and $9.0 million (Q1 2022), per Business Quant data.